GILD vs VRTX
Gilead Sciences vs Vertex Pharmaceuticals — AI-powered side-by-side comparison
| Metric | GILD | VRTX |
|---|---|---|
| AI Score | 66 | 55 |
| Price | $129.81 | $485.36 |
| P/E Ratio | 18.11× | 30.05× |
| ROE | 42.2% | 23.9% |
| Revenue Growth YoY | 3.5% | 10.1% |
| Gross Margin | 79.3% | 86.2% |
| Debt / Equity | 1.10× | 0.01× |
| Dividend Yield | 2.4% | — |
| RSI (14) | 49.2 | 43.8 |
| Beta | 0.3411 | 0.2937 |
| Expected Upside | +21.1% | +0.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GILD Full Analysis
VRTX Full Analysis